FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # Pure BPC 157 500 mcg, 60 capsules ProHealth.com FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner FDA considers adding a dozen peptides to its bulk drug compounding list RAPS